Can nanomedicines kill cancer stem cells?-Reference-Cited by-同舟云学术

Can nanomedicines kill cancer stem cells?

Published:2013-11 Issue:13-14 Volume:65 Page:1763-1783
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Zhao Yi,Alakhova Daria Y.,Kabanov Alexander V.

Funder

National Institutes of Health

Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health

China Scholarship Council PhD Scholarship

The Carolina Partnership, a strategic partnership between the UNC Eshelman School of Pharmacy and The University Cancer Research Fund through the Lineberger Comprehensive Cancer Center

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference271 articles.

1. Cancer stem cells: mirage or reality?;Gupta;Nat. Med.,2009

2. Primary bioassay of human tumor stem cells;Hamburger;Science,1977

3. Stem cells and cancer: two faces of eve;Clarke;Cell,2006

4. Heterogeneity in cancer: cancer stem cells versus clonal evolution;Shackleton;Cell,2009

5. Tumour stem cells and drug resistance;Dean;Nat. Rev. Cancer,2005

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential of Nanotechnology to Replace Cancer Stem Cells;Current Stem Cell Research & Therapy;2024-07

2. Bone Targeting Nanoparticles for the Treatment of Osteoporosis;International Journal of Nanomedicine;2024-02

3. Combination chemotherapy against colorectal cancer cells: Co-delivery of capecitabine and pioglitazone hydrochloride by polycaprolactone-polyethylene glycol carriers;Life Sciences;2023-11

4. Prostate Cancer Stem Cells: Biology and Treatment Implications;International Journal of Molecular Sciences;2023-10-04

5. CD71/CD44 dual-aptamer-gemcitabine conjugate for tumor co-targeting treatment of bladder cancer;Chemical Engineering Journal;2023-05